Douglas Plassche

This profile gathers the share dealings of Douglas Plassche in Elite Pharmaceuticals Inc. Over a trading history stretching from 27 April 2015 to 9 January 2026, the count stands at 13 filings.

The open-market record consists of 5 sales worth €1.1M, with no purchase. Outside the open market, there are 6 share grants and 2 option exercises.

The record was last updated on 13 January 2026 with an option exercise (€64k) in Elite Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.